DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Gaziano JM, Brotons C, Coppolecchia R. , et al; ARRIVE Executive Committee.
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
Lancet 2018;
392 (10152): 1036-1046
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.